Please use this identifier to cite or link to this item: https://hdl.handle.net/11499/7575
Title: Cardioprotective effect of clarithromycin on Doxorubicin-induced cardiac toxicity in rats
Authors: Doğan, Mustafa
Fırıncı, Fatih
Balcı, Yasemin I.
Gürses, Dolunay
Polat, Aziz
Ma Özdemir, Özmert
Enli, Yaşar
Akbulut, Metin
Şahin, Barbaros
Keywords: Cardiotoxity
Clarithromycin
Doxorubicin
Rat
clarithromycin
doxorubicin
glutathione
malonaldehyde
animal experiment
animal model
animal tissue
antioxidant activity
article
cardiotoxicity
controlled study
heart muscle
heart muscle fibrosis
heart protection
histology
inflammation
male
muscular dystrophy
nonhuman
rat
Publisher: UHOD - Uluslararasi Hematoloji Onkoloji Dergisi
Abstract: Doxorubicin is an anthracycline group antibiotic and has long been used as an antineoplastic agent. The most important side effect that limits the usage of doxorubicin is cardiotoxicity, which is observed at cumulative doses. We investigated the protective effect of clarithromycin that is known to have antioxidant and anti-inflammatory effects against Doxorubicin related cardiotoxicity. The aim of our study was to evaluate the effects of clarithromycin in the antioxidant enzyme status and myocardium of doxorobucine-treated rats. A total of 28 adult, male Wistar rats (200-250 g) were divided into 4 groups. Group I was the control group, rats in group 2 were administered doxorubicin, rats in group 3 were administered clarithromycin, and rats in group 4 were administered Doxorubicin + Clarithromycin. Following the scarification of all rats, antioxidant (glutathione) and oxidant (malodialdehyde) levels were measured in the cardiac tissue. Additionally, the cardiac muscles were evaluated histopathologically via hematoxylin eosin staining. The antioxidant amount (glutathione) was significantly higher in the treatment group compared to the doxorubicin group (p= 0.025), whereas the amount of oxidant (malondialdehyde) was significantly lower (p= 0.022). The histopathological examination revealed significant cardiotoxicity in the Doxorubicin group and significant reduction in the cardiotoxicity in the Doxorubicin + Clarithromycin group. The results obtained in this study provide evidence for the usefulness of the clarithromycin as a cardioprotective agent.
URI: https://hdl.handle.net/11499/7575
https://doi.org/10.4999/uhod.13068
ISSN: 1306-133X
Appears in Collections:Scopus İndeksli Yayınlar Koleksiyonu / Scopus Indexed Publications Collection
Tıp Fakültesi Koleksiyonu
TR Dizin İndeksli Yayınlar Koleksiyonu / TR Dizin Indexed Publications Collection
WoS İndeksli Yayınlar Koleksiyonu / WoS Indexed Publications Collection

Files in This Item:
File SizeFormat 
ac2459ae-5c21-42ea-96a7-86e951456e65.pdf2.31 MBAdobe PDFView/Open
Show full item record



CORE Recommender

SCOPUSTM   
Citations

4
checked on Sep 30, 2024

WEB OF SCIENCETM
Citations

2
checked on Sep 30, 2024

Page view(s)

138
checked on Aug 24, 2024

Download(s)

38
checked on Aug 24, 2024

Google ScholarTM

Check




Altmetric


Items in GCRIS Repository are protected by copyright, with all rights reserved, unless otherwise indicated.